- Home
- TREE vs NUVB Comparison
TREE vs NUVB Comparison
Compare TREE & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- NUVB
- Stock Information
- Founded
- TREE 1996
- NUVB 2018
- Country
- TREE United States
- NUVB United States
- Employees
- TREE N/A
- NUVB N/A
- Industry
- TREE Finance: Consumer Services
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- TREE Finance
- NUVB Health Care
- Exchange
- TREE Nasdaq
- NUVB Nasdaq
- Market Cap
- TREE 978.1M
- NUVB 1.1B
- IPO Year
- TREE N/A
- NUVB N/A
- Fundamental
- Price
- TREE $58.51
- NUVB $3.65
- Analyst Decision
- TREE Buy
- NUVB Strong Buy
- Analyst Count
- TREE 8
- NUVB 7
- Target Price
- TREE $65.38
- NUVB $8.43
- AVG Volume (30 Days)
- TREE 194.9K
- NUVB 6.7M
- Earning Date
- TREE 10-30-2025
- NUVB 11-05-2025
- Dividend Yield
- TREE N/A
- NUVB N/A
- EPS Growth
- TREE N/A
- NUVB N/A
- EPS
- TREE N/A
- NUVB N/A
- Revenue
- TREE $1,012,155,000.00
- NUVB $14,355,000.00
- Revenue This Year
- TREE $17.19
- NUVB $332.80
- Revenue Next Year
- TREE $7.58
- NUVB $360.12
- P/E Ratio
- TREE N/A
- NUVB N/A
- Revenue Growth
- TREE 51.65
- NUVB 900.35
- 52 Week Low
- TREE $33.50
- NUVB $1.54
- 52 Week High
- TREE $77.35
- NUVB $4.09
- Technical
- Relative Strength Index (RSI)
- TREE 29.76
- NUVB 61.90
- Support Level
- TREE $63.88
- NUVB $3.00
- Resistance Level
- TREE $71.17
- NUVB $3.88
- Average True Range (ATR)
- TREE 2.81
- NUVB 0.24
- MACD
- TREE -1.92
- NUVB 0.02
- Stochastic Oscillator
- TREE 2.21
- NUVB 68.59
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.